Ricardo Ramos
Analyst · Deutsche Bank
Thank you. Good morning, and thank you for joining us today. I'm pleased to report SQM's second quarter results, which reflect a strong performance across our main business lines. I would like to start by highlighting an important milestone for our lithium operations in Chile. In July, Novandino Litio, our association with Codelco, submitting the environmental and technical documentation for the Salar Futuro project to the authorities. Salar Futuro represents the next stage in the transformation of our operations in the Salar de Atacama, subject to the required approvals. The project contemplates approximately $3 billion of investment over 7 years and is designed to increase production while significantly reducing the environmental footprint of our operations. I would also like to highlight the contribution that our operations made to Chile. During the first half of this year, SQM and its subsidiaries accrue more than $1.6 billion in payments to the Chilean government including taxes, contribution to local governments and payments to CORFO. Moving to the lithium market. We achieved record quarterly sales volumes of more than 84,000 metric tons of lithium carbonate equivalent from our operations in Chile through Novandino Litio and in Australia through Covalent Lithium. As anticipated in our previous earnings report, lithium prices increased during the second quarter, supported by a strong-than-expected market demand. We now expect global lithium demand to exceed 2.1 million metric tons in 2026. We continue to expand our production capabilities in both Chile and Australia. In Chile, we expect Novandino Litio to produce between 280,000 and 290,000 metric tons of lithium carbonate equivalent this year and to have approximately 300,000 metric tons of production capacity by next year. In Australia, together with our partner Wesfarmers, we recently announced the expansion of the Mount Holland mine and concentrator, which is expected to double spodumene concentrate production capacity to approximately 350,000 metric tons per year corresponding to SQM shares of the project with first production expected in 2030. These investments reflect our long-term view of the lithium market and our confidence in the fundamentals of the energy transition. Moving to iodine, we once again delivered good results, supported by robust market demand and favorable pricing. We expect demand to remain robust. Our seawater pipeline is currently in its commissioning phase and will provide additional flexibility to optimize our production and respond to market conditions. We are now producing iodine from our four different operations, and we expect total iodine production to reach approximately 15,500 metric tons this year. Turning to specialty plant nutrition, we delivered another strong quarter supported by higher sales prices and volumes. We continue to expect full year sales volumes to increase by approximately 10% compared to 2025. Market conditions have benefited from supply constrained in certain markets, and we expect this condition to gradually normalize towards the end of the year. Finally, we have updated our capital expenditure outlook, we now included 2028, and we expect approximately total capital expenditures of approximately $3 billion over the 3 years '26-'28 period. This investment is mainly focused on supporting future growth and enhancing the competitiveness of our operations through lower production costs. Overall, we are encouraged by the performance delivered during the first half of the year and remain focused on executing our growth plans and creating long-term value for our shareholders. With that, I will turn the call and we can go, operator, to the Q&A. Thank you.